WGS
WGS
NASDAQ · Health Care

Genedx Holdings Corp

$40.77
+0.27 (+0.67%)
As of May 9, 1:26 AM ET ·
Financial Highlights (FY 2026)
Revenue
854.88M
Net Income
-42,030,885
Gross Margin
69.7%
Profit Margin
-4.9%
Rev Growth
+22.1%
D/E Ratio
0.23
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 69.7% 69.7% 62.2% 62.2%
Operating Margin -3.1% -2.8% 14.8% 14.6%
Profit Margin -4.9% -4.7% 14.8% 14.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 854.88M 699.98M 1.18B 1.24B
Gross Profit 596.20M 488.17M 732.20M 774.12M
Operating Income -26,159,444 -19,277,408 174.02M 181.42M
Net Income -42,030,885 -30,973,386 173.63M 181.68M
Gross Margin 69.7% 69.7% 62.2% 62.2%
Operating Margin -3.1% -2.8% 14.8% 14.6%
Profit Margin -4.9% -4.7% 14.8% 14.6%
Rev Growth +22.1% +22.1% -3.2% +14.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 217.38M 217.38M 881.91M 877.23M
Total Equity 950.08M 950.08M 1.15B 1.20B
D/E Ratio 0.23 0.23 0.77 0.73
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -28,715,473 -22,336,607 205.84M 224.41M
Free Cash Flow 141.12M 137.36M